Stopped: Sponsor decision
The purpose of the present study is to describe patient's perception of quality of life and effectiveness of ORALAIR® over a follow-up period up to 5 years, in real-life settings.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Health related quality of life
Timeframe: patients will be followed for the duration of the treatment, an expected average of 6 months/year